Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs

Neglected diseases caused by arenaviruses such as Lassa virus (LASV) and filoviruses like Ebola virus (EBOV) primarily afflict resource-limited countries, where antiviral drug development is often minimal. Previous studies have shown that many approved drugs developed for other clinical indications...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Herring, Shawn, Oda, Jessica M., Wagoner, Jessica, Kirchmeier, Delaney, O’Connor, Aidan, Nelson, Elizabeth A., Huang, Qinfeng, Liang, Yuying, DeWald, Lisa Evans, Johansen, Lisa M., Glass, Pamela J., Olinger, Gene G., Ianevski, Aleksandr, Aittokallio, Tero, Paine, Mary F., Fink, Susan L., White, Judith M., Polyak, Stephen J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2021
Pynciau:
Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097473/
https://ncbi.nlm.nih.gov/pubmed/33468464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01146-20
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg